Organisers : iLDLT Group Living Donor Liver Transplantation

Organisers

Our Organisers

The INTERNATIONAL LDLT GROUP

The international Living Donor Liver Transplantation Group, has been founded as a corollary of the successful FIVE CENTRE ASIAN LDLT meetings. These centers were Kyoto (Prof. Koichi TANAKA) and Tokyo (Prof. Masatoshi MAKUUCHI) Universities, Kaohsiung Chung Gang Memorial Hospital (Prof. Chao-Long CHEN), Queen Elisabeth Hospital Hong Kong (Profs ST.Fan and CM.LO).

The experts belonging to these centers finally took the initiative to create in 2014 a formal study group focusing on the further development of LDLT.

 

AIM

  • to spread and promote knowledge about LDLT on a worldwide scale
  • to exchange the expertise between LDLT the medical and surgical leaders in order to continuously improve the results even in very sick patients0

The office is based in Seoul, South Korea.

 

iLDLT Group Council Members (2022-23)

President Hiroto Egawa Japan Tokyo Womens' Medical University
Secretary General Kwang-Woong Lee Korea Seoul National University Hospital
Executive Secretary Susumu Eguchi Japan Nagasaki University Graduate School of Biomedical Sciences
Executive Member Avi Soin India Medanta Institute of Liver Transplantation and Regenerative Medicine
Honorary Advisory Council Sung-Gyu Lee Korea Asan Medical Center
Sheung Tat Fan Hong Kong Hong Kong Sanatorium & Hospital
Advisory Council Kyung-Suk Suh Korea Seoul National University Hospital
Jan Lerut Belgium University Hospitals Saint Luc
Kim Olthoff USA Hospital of the University of Pennsylvania
Shusen Zheng China The First Affiliated Hospital of Zhejiang University
Chao-Long Chen Taiwan Kaohsiung Chang Gung Memorial Hospital
Mohamed Rela India Dr. Rela Insitute and Medical Center
Yaman Tokat Turkey Florence Nightingale Hospital
Giuliano Testa USA Baylor University Medical Center
Mark Cattral Canada University of Toronto
Auditor Refaat Kamel Egypt Ain Shams University
Treasurer Dieter Broering Saudi Arabia King Faisal Specialist Hospital and Research Centre
Council Subhash Gupta India Max Center For Liver And Biliary Sciences, Max Super Speciality Hospital
Daniel Azoulay France Paul Brousse Hospital
Jia-Hong Dong China Beijing Tsinghua University
Abhinav Humar USA University of Pittsburgh
Toru Ikegami Japan The Jikei University School of Medicine
Mureo Kasahara Japan National Center for Child Health and Development
Nam-Joon Yi Korea Seoul National University Hospital
Dong-Hwan Jung Korea Asan Medical Center
Yao-Li Chen Taiwan Changhua Christian Hoapital
Ilgin Ozden Turkey Istanbul University
Deniz Balci Turkey Ankara University School of Medicine
Dong Jin Joo Korea Severance Hospital
Nobuhisa Akamatsu Japan Tokyo University
Tiffany Cho-Lam Wong Hong Kong The University of Hong Kong
Kang He China Renji Hospital,affiliated by Shanghai Jiaotong University
Wellington Andraus Brazil Sao Paulo University School of Medicine

 

Vanguard Multi-center Study Project Committee

Director Toru Ikegami Japan The Jikei University School of Medicine
Member Nobuhisa Akamatsu Japan University of Tokyo
Johanna Bayer USA Baylor University Medical Center
Cheng-Yen Chen Taiwan Taipei Veterans General Hospital
Ramkiran Cherukuru India Dr. Rela Institute and Medical Centre
Rajesh Dey India Max Saket Hospital
Kenei Furukawa Japan The Jikei University School of Medicine
Amar Gupta USA Baylor University Medical Center
Takanobu Hara Japan Nagasaki University
Kang He China Renji Hospital, Shanghai Jiao Tong University
Taizo Hibi Japan Kumamoto University
Suk Kyun Hong Korea Seoul National University Hospital
Balradja Inbaraj India Max Saket Hospital
Budi Irwan Indonesia National Hospital H. Adam Malik
Takashi Ito Japan Kyoto University
Jagadeesh Krishna India Max Saket Hospital
Jae Keun Lee Korea Yonsei University College of Medicine
Niang-Cheng Lin Taiwan Taipei Veterans General Hospital
Yuichi Masuda Japan Shinshu University
Aldwin Ong Taiwan Chang Gung Memorial Hospital
Rajesh Rajalingam India Dr. Rela Institute and Medical Centre
Acharya Rajigopal India Max Saket Hospital
Srinivas Reddy India Gleneagles Global Hospital
Jinsoo Rhu Korea Samsung Medical Center
Yukihiro Sanada Japan Jichi University
Keita Shimata Japan Kumamoto University
Takeo Toshima Japan Kyushu University Hospital
Hajime Uchida Japan National Center for Child Health and Development
Tiffany Cho-Lam Wong Hong Kong The University of Hong Kong
Young-In Yoon Korea Asan Medical Center, University of Ulsan College of Medicine
Dong Zhao China Renji Hospital, School of Medicine, Shanghai Jiao Tong University

 

YouTube Committee

Director Deniz Balci Turkey Ankara University
Member Samir Abu-Gazala United States Hospital of the University of Pennsylvania
Chee Chien Yong Taiwan Chang Gung Memorial Hospital
Young Rok Choi Korea Seoul National University Hospital
Nicolas Goldaracena United States University of Virginia Health System
Gregory McKenna United States Baylor Scott & White Health

The Centre for Liver and Biliary Sciences (CLBS) at Max Super Specialty Hospital, Saket is one of the largest liver transplant programs in the world. The center performs more than 250 liver transplants annually and has accumulated an experience in more than 3500 liver transplant surgeries. The center also performs a variety of complex hepatobiliary and pancreatic surgeries and is at the forefront of HPB Oncology.

We as a team of surgeons, anesthetists, intensivists, radiologists, and nurses have been involved in the care of patients with liver disease and transplantation since 1998 when liver transplantation was a rarity in India. The center has been growing ever since and has made significant contributions to the field of liver surgery. It has been a great accomplishment for the team to have trained many aspiring liver surgeons and has helped in establishing various liver transplant units across the globe. Many teams including teams from the USA, Malaysia, Kenya, Kazakhstan, Myanmar, Pakistan, Nepal, and Bangladesh have been trained. Such teams from India also have been encouraged notably by the centers like ILBS New Delhi, SMS Medical College Jaipur, Cuttack Medical College, Bangalore Medical College, and King George's Medical University Lucknow. It gives a great pride to know that many of our trainees have continued their work in the field of liver and transplant surgery and have established themselves across the world.

CLBS has been involved in the care of patients from over 20 countries. It is a special place to many as it offers world-class facilities and treatment options at par with the best international centers anywhere, but at a much more affordable cost and with consistent results. Over the years the team has pioneered Living Donor Liver Transplantation and HPB Oncology in India and has introduced numerous innovations to make the surgery safe and to improve the outcomes of these complex procedures of surgeons and physicians.

CLBS has always focussed greatly on training the next generations and imparting knowledge and holding a platform to exchange information and share experiences with one another. With an aim to encourage and bring all the people involved in this field, our constant effort has been to expand this platform to invite scientists, physicians, surgeons, and trainees to participate in these annual conferences, which have been extending their reach every year. The COVID pandemic has affected all of us in many ways, but we still would like to continue our pursuit of knowledge and play our role in bringing the transplant community together.

The 7th CLBS Symposium is being held from 17th to 19th September 2021 and the theme this year is "The Kidney in Liver Transplant". Topics related to anaesthesia, critical care, surgery, and hepatology would be discussed threadbare. These sessions address the important topics in the mentioned theme. We hope that this conference will also help young surgeons, anesthetists, and hepatologists and we encourage their active participation. We have invited leaders in their respective fields to share with all of us their experiences and we hope this will be a great opportunity to learn from the masters the latest updates and future directions in transplant surgery and hepatology.

In view of this ongoing Covid-19 pandemic, the meeting will have a virtual format also for the convenience of participants from outside NCR.

The Liver Transplant Society of India (LTSI) has been established with the primary objective of facilitating the growth of liver transplantation and allied fields in India by creating awareness, promotion, education, professional training, establishing professional standards, enhancing academic activities, and conducting and promoting medical research.

 

AIM:

  • To establish and encourage the highest professional and ethical standards in the practice of liver transplantation in India.
  • To protect the rights and privileges of the members, solve grievances of members and make rules when deemed necessary relating to conduct, discipline, and professional conduct of members.
  • To interact with the state and central government in formulating laws, rules, and policies in the field of liver transplant and allied subjects.
  • To arrange and conduct scientific meetings, CME programs, training, and educational courses, and to grant orations, awards, certificates, prizes, fellowships, scholarships, stipends, and remuneration to students, members, and scholars to undertake training and research in the field of liver transplantation and allied subjects.
  • To disseminate knowledge and updates, provide authoritative advice, information and opinion and create awareness about liver transplant and allied subjects to other professional organizations, government, patients, and the public.
  • To print, publish, distribute or sell books, pamphlets, pictures, periodicals, bulletins, journals, newspapers or magazines, or any material in print or electronic forms such as websites, email or social media, or any other material about liver transplantation and allied subjects.
  • To establish and maintain print and electronic reference libraries of books, journals, periodicals, magazines, newspapers, and audio-visual materials related to liver transplantation and allied subjects.
  • To facilitate or aid other individuals or organizations involved in the promotion of liver transplantation and allied subjects.
  • To encourage and advance research, study, and practice of science and art of liver transplant surgery, transplant hepatology, liver anesthesia, and critical care and other allied specialties such as transplant pathology, diagnostic and interventional radiology, organ donation, infection, and immunosuppression and provide training, research and fellowship opportunities in collaboration with various centers.
  • To facilitate new liver transplant centers in India with know-how, understanding of the legal processes, and training opportunities in collaboration with existing centers.
  • To facilitate interaction amongst students, clinicians, allied professionals,s and scientists involved in liver transplantation and allied subjects regionally, nationally, and internationally for the exchange of scientific information, and promotion of scientific research and experimental work in this field by organizing conferences, seminars, symposia, workshops, continuing medical education programs and other academic programs.
  • To collaborate with national and international governments, semi-government institutions, universities, non-government organizations, societies, health agencies, patient support groups and relevant public and private entities, patients and other individuals to facilitate improvements and innovations in surgical techniques, clinical applications, drugs, consumables, instruments and equipment related to liver transplantation and allied subjects and organize or participate in regional, national and international conferences, seminars, symposia, workshops, continuing medical education programs, exhibitions and other programs to promote such innovations.
  • To establish a national registry for liver transplantation and encourage members to voluntarily update information in the registry.
  • To facilitate the formation and smooth running of patient support groups.
  • To collaborate with, accept grants, donations, endowments, movable or immovable assets, subscriptions, or other income or undertake projects with or without conditions from national and international governments, semi-government institutions, universities, non-government organizations, societies, health agencies, other public and private entities, patient support groups, patients and other individuals for fulfilling the objectives of the society.
  • The society is authorized to hold funds and utilize them to fulfilling the objectives of the society.
  • To do all such things as may be incidental or conducive to the attainment of all or any of the above objectives.
  • All the income, earnings, and movable and immovable property of the society shall be solely utilized and applied towards the promotion of the society’s aims and objectives as set forth in the memorandum of the association, and no portion thereof shall be paid or transferred directly or indirectly by way of dividends, bonus, profits or in any manner whatsoever to the present or past members of the society or to any person claiming through any one or more of the present or past members of the Society. No member of the society shall have any personal claim on any moveable property of the society or make any profit, whatsoever, by virtue of his/her membership.

Send a Query